The cell culture protein surface coatings market is expected to register a CAGR of nearly 9.5%, during the forecast period. The optimization of cell culture environment enables cells to grow, function, and survive in a realistic and representative manner. The surface coating of cell culture with protein involves coating the cell culture surface with extracellular matrix or protein components, in order to improve the proliferation and adhesion of the cells in-vitro. Corning is among the oldest companies advanced in the cell-culture surface technology, with a long legacy of developing new surfaces with expanded capabilities.
Some of the major drivers for this market include increasing research related to stem cells. Recent years have witnessed the high importance of stem cells in treating many chronic diseases, and it has been observed that stem cells have great potential for cell therapy, protein cell culture, tissue engineering, and regenerative medicine. The other drivers include growing demand for protein therapeutics and targeted therapy, as well as a steady increase in the preference toward 3D cell cultures over 2D cell cultures. However, there are several government laws as well as individual societies’ norms, which inhibit the use of animal-sourced protein coating. This restricts the growth of the overall market. With that, there is a high cost associated with cell culture protein.
Key Market Trends
Synthetic Proteins are Expected to Provide Fast Growth for the Market Over the Forecast Period
Consequently, artificial proteins are the leading category of protein sources in the global cell culture protein surface coatings market. The synthetic proteins have a relatively lower risk proposition, as they are less prone to contamination. There is a wide range of applications, which scientific researchers in their studies have observed, like potential early treating of diseases like cancer and diabetes. There is a growing application related to protein therapeutics and technological advancement. Moreover, it is an alternative origin of animal source, which drives its importance in research communities and markets. Thus, it is estimated to grow the fastest, over the forecast period.
North America is Estimated to Hold the Largest Share in the Market
North America is well known for its cell culture laboratories and funding for research in the healthcare domain. Every year, in the United States, the National Institutes of Health (NIH) heavily funds stem cell research. For research in cancer diseases and personalized medicine, the National Cancer Institute (NCI) allocates high funds to universities and companies collaborating with research centers. Such factors boost the importance of cell culture activities. The healthcare expenditure is, therefore, high in the United States and Canada.
The major market players are focusing on technological advancements in protein technology and cell culture techniques. Some of the major players in the market are Corning Incorporated, Greiner Bio-One International AG, Merck Millipore, Qiagen N.V., and Thermo Fisher Scientific Inc.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support